Synowiecki Mateusz Adam, Perk Lars Rutger, Nijsen J Frank W
1Radboudumc, Radboud Translational Medicine B.V, Geert Grooteplein 21 (route 142), 6525EZ Nijmegen, The Netherlands.
2Radboudumc, Dept. of Radiology and Nuclear Medicine, Geert Grooteplein-Zuid 10, 6525GA Nijmegen, The Netherlands.
EJNMMI Radiopharm Chem. 2018;3(1):3. doi: 10.1186/s41181-018-0038-z. Epub 2018 Feb 20.
The global network of cyclotrons has expanded rapidly over the last decade. The bulk of its industrial potential is composed of small medical cyclotrons with a proton energy below 20 MeV for radionuclides production. This review focuses on the recent developments of novel medical radionuclides produced by cyclotrons in the energy range of 3 MeV to 20 MeV. The production of the following medical radionuclides will be described based on available literature sources: Tc-99 m, I-123, I-124, Zr-89, Cu-64, Ga-67, Ga-68, In-111, Y-86 and Sc-44. Remarkable developments in the production process have been observed in only some cases. More research is needed to make novel radionuclide cyclotron production available for the medical industry.
在过去十年中,全球回旋加速器网络迅速扩张。其大部分工业潜力由质子能量低于20兆电子伏的小型医用回旋加速器组成,用于生产放射性核素。本综述重点关注能量范围在3兆电子伏至20兆电子伏的回旋加速器所产生的新型医用放射性核素的最新进展。将根据现有文献来源描述以下医用放射性核素的生产情况:锝-99m、碘-123、碘-124、锆-89、铜-64、镓-67、镓-68、铟-111、钇-86和钪-44。仅在某些情况下观察到生产过程有显著进展。需要进行更多研究,以使新型放射性核素的回旋加速器生产能够应用于医疗行业。